Exosome-Loaded Zinc Sulfide Nanoparticles Therapy for Psoriasis: Immune Regulation and Skin Repair by Targeting IL-23/IL-17A–NF-κB Pathway
, EXO-ZnS NPs significantly attenuated psoriatic symptoms, and Severity Index scores, reduced inflammatory mediators (IL-23, IL-17a, TNF-α, MCP-1, NLRP3), mitigated oxidative stress, downregulated proliferative markers (Ki-67, MMP-9), and inhibited VEGF-mediated angiogenesis. collectively restored epidermal structure and improved skin architecture. EXO-ZnS NPs synergistically combine the regenerative and immunomodulatory effects of exosomes with the intrinsic anti-inflammatory and antioxidant activities of ZnS NPs, offering a novel promising, dual-action therapeutic platform for effective and sustained psoriasis management.
Authors
- Mohamed S. Kishta (ORCID: https://orcid.org/0000-0002-2314-8820)
- Asmaa Osama B. S. Osman
- Neveen A. Salem (ORCID: https://orcid.org/0000-0003-1520-122X)
- Noha A. Mowaad
- Rania Elgohary
- Mohamed Reda
Institutions
- National Institute for Health and Care Research (GB)
- Institute of Clinical Research (GB)
- Energy Research Company (United States) (US)
- Assiut University (EG)
Publication Details
- Journal
- Journal of drug targeting
- Published
- 2026-07-22
- DOI
- https://doi.org/10.1080/1061186x.2026.2708742
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00